A Study to Evaluate in Patients With Parkinsonian Type Disorders

Clinical trial NCT03683225 · UNKNOWN

Trial details

NCT number: NCT03683225
Sponsor: Chase Therapeutics Corporation
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Parkinson Disease

Start date: 2019-04-01
Primary completion: 2025-12-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.